About Us
COMPANY PROFILE
NINGBO SYNTAME BIOTECH CO.,LTD.
Ningbo SYNTAME Biotech Co., Ltd. (Brand: SYNTAME) is a National level Science and Technology Enterprise specializing in the R&D, production, and sales of pharmaceutical materials. It is committed to innovative drug process research, development, and optimization of drug replication processes to control costs, providing various drug-related products and technical solutions for the domestic and international pharmaceutical markets.
The company mainly focuses on the material of cardiovascular, diabetes and antipsychotic drugs, with key products such as Ezetimibe, Gliquidone, Duloxetine and GLP-1 excipients including Salcaprozate Sodium (SNAC) and Sodium Caprate for Semaglutide tablet, Tirzepatide tablet and peptide tablets.
The core R&D team has over 20 years of experience in drug development and production, with a fixed production base and a production capacity of over a thousand tons. They can produce special reactions such as Hydrogenation and Nitration, and undertake customized processing of high-end pharmaceutical intermediates and API. Our products are exported to international and domestic markets such as Europe, the United States, and Southeast Asia and so on.
The company adheres to the management philosophy of "quality first, technological innovation", strengthens optimization management and technological innovation, and has passed EcoVadis certification, ISO9001: 2015 Quality Management System; ISO14001: 2015 Environmental Management System Certification; ISO45001: 2018 Occupational Health and Safety Management System Certification, strengthening management and skills training. The company has an independent research and development system, currently holds 3 invention patents, accepts 3 invention patents, and adheres to technological innovation.
Based on the market and closely following the development of the pharmaceutical industry, we sincerely invite domestic and foreign customers to develop together and achieve a win-win situation, and strive for the cause of human health.
COMPANY DEVELOPMENT HISTORY
2025
ECOVADIS certificated
2024
Outstanding incubated enterprises
2024
ECOVADIS certificated
2023
Ningbo Equity Exchange Center has innovatively listed with the code 783899. Certified by CQC for ISO9001, ISO14001, ISO45001, and CNAS. Outstanding incubated enterprises.
FACTORY FACILITIES
TESTING CENTER
HONOR
The company has passed the ISO9001:2015 quality management system; ISO14001: 2015 Environmental Management System Certification; ISO45001: 2018 Occupational Health and Safety Management System Certification, strengthening management and skills training. The company has an independent R&D system, currently holds 3 invention patents, accepts 3 invention patents, and adheres to technological innovation.
WHO CHOSE US?
No.298 Mingguang Road, Urban Industrial Park, Yinzhou District, Ningbo City, Zhejiang Province, P.R. China
